Table II.
Cyclooxygenase-1 (COX-1) | Forward Reverse Probe |
5′-TGT TCG GTG TCC AGT TCC AAT A-3′ 5′-ACC TTG AAG GAG TCA GGC ATG AG-3′ 5′-CGC AAC CGC ATT GCC ATG GAG T-3′ |
Cyclooxygenase-2 (COX-2) | Forward Reverse Probe |
5′-CCT TCC TCC TGT GCC TGA TG-3′ 5′-ACA ATC TCA TTT GAA TCA GGA AGC T-3′ 5′-TGC CCG ACT CCC TTG GGT GTC A-3′ |
Prostaglandin E2 receptor type 1 (EP1) | Forward Reverse Probe |
5′-AGA TGG TGG GCC AGC TTG T-3′ 5′-GCC ACC AAC ACC AGC ATT G-3′ 5′-CAG CAG ATG CAC GAC ACC ACC ATG-3′ |
Prostaglandin E2 receptor type 2 (EP2) | Forward Reverse Probe |
5′-GAC CGC TTA CCT GCA GCT GTA C-3′ 5′-TGA AGT TGC AGG CGA GCA-3′ 5′-CCA CCC TGC TGC TGC TTC TCA TTG TCT-3′ |
Prostaglandin E2 receptor type 3 (EP3) | Forward Reverse Probe |
5′-GAC GGC CAT TCA GCT TAT GG-3′ 5′-TTG AAG ATC ATT TTC AAC ATC ATT ATC A-3′ 5′-CTG TCG GTC TGC TGG TCT CCG CTC-3′ |
Prostaglandin E2 receptor type 4 (EP4) | Forward Reverse Probe |
5′-ACG CCG CCT ACT CCT ACA TG-3′ 5′-AGA GGA CGG TGG CGA GAA T-3′ 5′-ACG CGG GCT TCA GCT CCT TCC T-3′ |
Prostaglandin F2α receptor (FP) | Forward Reverse Probe |
5′-GCA GCT GCG CTT CTT TCA A-3′ 5′-CAC TGT CAT GAA GAT TAC TGA AAA AAA TAC-3′ 5′-CAC AAC CTG CCA GAC GGA AAA CCG-3′ |
Thromboxane receptor (TBXR) | Forward Reverse Probe |
5′-TGG TGG TGG CCA GCG T-3′ 5′-CGG GTT TCG CAG CAC TGT-3′ 5′-TGC CCC TTC TGG TCT TCA TCG CCC-3′ |
Prostacyclin receptor (IP) | Forward Reverse Probe |
5′-GCC CTC CCC CTC TAC CAA-3′ 5′-TTT TCC AAT AAC TGT GGT TTT TGT G-3′ 5′-CCA AGA GCC AGC CCC CTT TCT GC-3′ |
Phosphodiesterase 4B | Forward Reverse Probe |
5′-CCT TCA GTA GCA CCG GAA TCA-3′ 5′-CAA ACA AAC ACA CAG GCA TGT AGT T-3′ 5′-AGC CTG CAG CCG CTC CAG CC-3′ |
18S | Forward Reverse Probe |
5′-CGT CTA CCA CAT CCA AGG AA-3′ 5′-GCT GGA ATT ACG GGG GCT-3′ 5′-TCG TGG CAC CAG ACT TGC CCT C-3′ |